Association between single nucleotide polymorphisms in DNA polymerase kappa gene and breast cancer risk in Chinese han population: A strobe-compliant observational study
An Anthem plan may cover Wegovy when doctors prescribe it for an FDA-approved medical indication and if the patient meets the following criteria: Chronic weight management in people with: Obesity, generally defined as having a body mass index (BMI) of 30 kg/m2 or higher
Administered via injection, Semaglutides dosing schedule varies depending on the intended use
The cost offsets observed in our model were driven mainly by T2D microvascular complications, gout, OSA, and CV events in the non-T2D cohort (-32 664, -18 478, -10 478, and -13 093 per patient lifetime, respectively), and by gout and CV events in the T2D cohort (-32 666 and 15 904 per patient lifetime)